News headlines about Catamaran Corp (NASDAQ:CTRX) have been trending somewhat negative on Wednesday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Catamaran Corp earned a daily sentiment score of -0.11 on Accern’s scale. Accern also gave media coverage about the healthcare company an impact score of 47.407736961717 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
COPYRIGHT VIOLATION NOTICE: This report was first posted by BBNS and is the property of of BBNS. If you are accessing this report on another publication, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The legal version of this report can be read at https://baseballnewssource.com/markets/somewhat-critical-press-coverage-somewhat-unlikely-to-affect-catamaran-corp-nasdaqctrx-share-price-updated-updated/1252614.html.
About Catamaran Corp
Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies.
Receive News & Ratings for Catamaran Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catamaran Corp and related companies with our FREE daily email newsletter.